Fierce Biotech August 27, 2024
The FDA has cleared its first automated insulin pump for adults with Type 2 diabetes, with Insulet’s Omnipod 5 delivery system opening the door to a population of more than 6 million people.
That includes about 2.5 million people who require multiple injections of insulin per day, according to Insulet. The company also estimates that only a quarter of people taking insulin to manage their Type 2 diabetes are meeting their HbA1c goals of 7% or less.
Now, they will have access to the same technology employed by people with Type 1 diabetes, with Insulet’s tubeless Omnipod system being able to connect with a wearable continuous glucose monitor to automatically detect blood sugar levels and adjust insulin doses accordingly.
“The...
Today's Sponsors
Today's Sponsor